Literature DB >> 10644500

Cancer surgery: the last 25 years.

A J Bremers1, E J Rutgers, C J van de Velde.   

Abstract

Surgery is, and always has been, the main treatment modality of solid tumours. For a long period, it consisted of a number of surgical procedures dictated by basic oncologic principles, most of which are still adhered to. Over the last few decades, increased understanding of the disease, new or improved diagnostic facilities, novel and perfected adjuvant treatments, improved surgical techniques and daring challenges to established dogmas have all contributed to the development of surgical oncology. The heritage from the past came under close scrutiny, and the fruits of basic and clinical science were added to an ever expanding body of knowledge. It is impossible to review all developments in surgical oncology of the last 25 years in one comprehensive paper. Therefore we have restricted ourselves to those items that appear most representative for the changes that have taken place, and those diseases that have the greatest numerical impact. Copyright 1999 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  1999        PMID: 10644500     DOI: 10.1053/ctrv.1999.0147

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  3 in total

1.  Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer.

Authors:  Bin Liang; Shan Wang; Xue-Guang Zhu; Yong-Xiang Yu; Zhi-Rong Cui; You-Zhi Yu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

Review 2.  Evolution of the Application of Techniques Derived from Abdominal Transplant Surgery in Urologic Oncology.

Authors:  Javier González; Jeffrey J Gaynor; Mahmoud Alameddine; Gaetano Ciancio
Journal:  Curr Urol Rep       Date:  2018-02-05       Impact factor: 3.092

3.  Prognostic value of RKIP and p-ERK in gastric cancer.

Authors:  Yoshitaka Fujimori; Mikito Inokuchi; Yoko Takagi; Keiji Kato; Kazuyuki Kojima; Kenichi Sugihara
Journal:  J Exp Clin Cancer Res       Date:  2012-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.